Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marisa Iborra

Showing results (51-60 of 92) with videos related to

Pageof 10
Sort By:
Inflammatory Bowel Diseases|June 24, 2017
Incidence and Management of Recurrence in Patients with Crohn's Disease Who Have Undergone Intestinal Resection: The Practicrohn StudyEugeni Domènech, Valle Garcia, Marisa Iborra, et al.
Scientific Reports|May 12, 2021
Evaluation of changes in intestinal microbiota in Crohn's disease patients after anti-TNF alpha treatmentLaura Sanchis-Artero, Juan Francisco Martínez-Blanch, Sergio Manresa-Vera, et al.
Journal of Crohn'S & Colitis|June 8, 2026
Risk of symptomatic leishmaniasis in patients with inflammatory bowel disease receiving biologic therapy in an endemic Mediterranean region: a population-based case-control studyLeticia Gimeno-Pitarch, Marisa Iborra, Ana Crespo, et al.
Expert Review of Gastroenterology & Hepatology|June 18, 2019
Endoscopic follow-up and therapeutic attitude after ileocolonic resection in a nationwide Spanish cohort of Crohn's disease patients: the Practicrohn studyManuel Barreiro-De Acosta, Eugeni Domènech, María Dolores Martín Arranz, et al.
Scandinavian Journal of Gastroenterology|November 7, 2023
Real-world long-term effectiveness of ustekinumab in ulcerative colitis: results from a spanish open-label cohortMarisa Iborra, Rocio Ferreiro-Iglesias, Martín-Arranz Maria Dolores, et al.
Frontiers in Immunology|January 2, 2026
Real-world effectiveness of vedolizumab in refractory pouchitis: a focus on biomarker changes during intravenous to subcutaneous transition (POUCHIVED study)Leticia Gimeno-Pitarch, Elena Céspedes-Martínez, Rocío Ferreiro-Iglesias, et al.
International Journal of Molecular Sciences|December 23, 2022
The Genetic Diversity and Dysfunctionality of Catalase Associated with a Worse Outcome in Crohn's DiseaseMarisa Iborra, Inés Moret, Enrique Busó, et al.
Digestive Diseases (Basel, Switzerland)|August 22, 2024
Efficacy of Beclomethasone Dipropionate in Lowering Fecal Calprotectin Levels in Patients with Ulcerative Colitis in Clinical Remission and at Risk of Relapse: The Becalcu Randomized, Controlled TrialDaniel Ginard, Manuel Barreiro-de Acosta, Pilar Nos, et al.
Journal of Crohn'S & Colitis|April 15, 2014
Risk of colectomy in patients with ulcerative colitis under thiopurine treatmentAlex Cañas-Ventura, Lucia Márquez, Elena Ricart, et al.
Journal of Clinical Medicine|December 9, 2023
Splanchnic Vein Thrombosis in Inflammatory Bowel Disease: An Observational Study from the ENEIDA Registry and Systematic ReviewMaria Puig, Helena Masnou, Francisco Mesonero, et al.
Pageof 10

Showing results (51-60 of 92) with videos related to

Sort By:
Pageof 10
Inflammatory Bowel Diseases|June 24, 2017
Incidence and Management of Recurrence in Patients with Crohn's Disease Who Have Undergone Intestinal Resection: The Practicrohn StudyEugeni Domènech, Valle Garcia, Marisa Iborra, et al.
Scientific Reports|May 12, 2021
Evaluation of changes in intestinal microbiota in Crohn's disease patients after anti-TNF alpha treatmentLaura Sanchis-Artero, Juan Francisco Martínez-Blanch, Sergio Manresa-Vera, et al.
Journal of Crohn'S & Colitis|June 8, 2026
Risk of symptomatic leishmaniasis in patients with inflammatory bowel disease receiving biologic therapy in an endemic Mediterranean region: a population-based case-control studyLeticia Gimeno-Pitarch, Marisa Iborra, Ana Crespo, et al.
Expert Review of Gastroenterology & Hepatology|June 18, 2019
Endoscopic follow-up and therapeutic attitude after ileocolonic resection in a nationwide Spanish cohort of Crohn's disease patients: the Practicrohn studyManuel Barreiro-De Acosta, Eugeni Domènech, María Dolores Martín Arranz, et al.
Scandinavian Journal of Gastroenterology|November 7, 2023
Real-world long-term effectiveness of ustekinumab in ulcerative colitis: results from a spanish open-label cohortMarisa Iborra, Rocio Ferreiro-Iglesias, Martín-Arranz Maria Dolores, et al.
Frontiers in Immunology|January 2, 2026
Real-world effectiveness of vedolizumab in refractory pouchitis: a focus on biomarker changes during intravenous to subcutaneous transition (POUCHIVED study)Leticia Gimeno-Pitarch, Elena Céspedes-Martínez, Rocío Ferreiro-Iglesias, et al.
International Journal of Molecular Sciences|December 23, 2022
The Genetic Diversity and Dysfunctionality of Catalase Associated with a Worse Outcome in Crohn's DiseaseMarisa Iborra, Inés Moret, Enrique Busó, et al.
Digestive Diseases (Basel, Switzerland)|August 22, 2024
Efficacy of Beclomethasone Dipropionate in Lowering Fecal Calprotectin Levels in Patients with Ulcerative Colitis in Clinical Remission and at Risk of Relapse: The Becalcu Randomized, Controlled TrialDaniel Ginard, Manuel Barreiro-de Acosta, Pilar Nos, et al.
Journal of Crohn'S & Colitis|April 15, 2014
Risk of colectomy in patients with ulcerative colitis under thiopurine treatmentAlex Cañas-Ventura, Lucia Márquez, Elena Ricart, et al.
Journal of Clinical Medicine|December 9, 2023
Splanchnic Vein Thrombosis in Inflammatory Bowel Disease: An Observational Study from the ENEIDA Registry and Systematic ReviewMaria Puig, Helena Masnou, Francisco Mesonero, et al.
Pageof 10